Ostaven (Alendronate Sodium)

Alendronate sodium, the active ingredient in Ostaven, is a bisphosphonate presented as a tablet for oral use. It is used to treat osteoporosis and other bone‑loss conditions in post‑menopausal women and men at risk of fractures. GNH USA supplies Ostaven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ostaven is a bisphosphonate that acts on bone metabolism disorders. - Osteoporosis: Reduces the risk of vertebral and hip fractures in post‑menopausal women and men. - Paget’s disease of bone: Helps normalize bone remodeling. - Glucocorticoid‑induced osteoporosis: Lowers fracture risk in patients on long‑term steroid therapy.

Adverse reactions to alendronate may range from mild to serious.

Common Side Effects: - Upper gastrointestinal irritation: heartburn, dyspepsia, or nausea. - Musculoskeletal pain: joint or muscle aches. - Headache. - Transient flu‑like symptoms.

Serious or Rare Side Effects: - Osteonecrosis of the jaw (ONJ). - Atypical femoral fractures. - Severe esophageal ulceration or erosion. - Acute hypersensitivity reactions, including anaphylaxis.

When prescribing Ostaven, clinicians should consider several safety aspects. - Assess renal function: dose adjustment may be needed in impaired kidneys. - Ensure proper administration: take with a full glass of water on an empty stomach, remain upright for at least 30 minutes. - Review concomitant medications: avoid concurrent use with NSAIDs or oral steroids. - Monitor calcium and vitamin D status: supplement if deficient. - Store at below 25°C: keep in the original packaging, protect from moisture.

Allenac S S ​ S ​ …

Major Interactions (  "); -  ");",